May 16, 2018 By Rick Bowen HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders
Aug 13, 2015 By Rick Bowen HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.
